The reintroduction of ALKBH5 into the USP36-deleted GSC cells significantly mitigated the inhibitory impact observed with USP36 knockout, particularly in cell proliferation, stemness, and tumor growth of the GSC cells. The gene discussed is ALKBH5; the disease is neoplasm.